Analyst Ratings For Alliance Pharma plc (LON:APH)
Today, Numis Securities reiterated its Add rating on Alliance Pharma plc (LON:APH) with a price target of GBX 115.
There are 1 Hold Ratings, 1 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.
The current consensus rating on Alliance Pharma plc (LON:APH) is Buy with a consensus target price of GBX 92.50 per share, a potential .
Some recent analyst ratings include
- 9/19/2018-Alliance Pharma plc (LON:APH) had its Add rating reiterated by Numis Securities with a GBX 115 price target
- 9/13/2017-Alliance Pharma plc (LON:APH) had its not rated rating reiterated by N+1 Singer
- 9/13/2017-Alliance Pharma plc (LON:APH) has coverage initiated with a Buy rating and GBX 59 price target
About Alliance Pharma plc (LON:APH)
Alliance Pharma plc operates as a specialty pharmaceutical company in the United Kingdom, rest of Europe, and internationally. The company acquires, markets, and sells pharmaceutical products. It acquires the rights of established products, and owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products. The company also provides prescription only medicines, over the counter medications, cosmetics, and nutritional supplements, as well as medical devices. In addition, it offers products in various therapeutic areas, including acquired healthcare, cardiovascular, central nervous system, child health, consumer health, dermatology, endocrinology, gastroenterology, obstetrics and gynecology, oral health, oncology, stoma care, toxicology, travel health, urology, vitamins and minerals, and others. Further, the company provides the Kelo-Cote, a formula silicone treatment used for prevention and forming of scars; MacuShield, an eye care supplement; and Vamousse, a pesticide free consumer healthcare product for prevention and treatment of human heal lice. The company distributes its products through wholesalers, retail pharmacies, hospitals, and network of distributors. Alliance Pharma plc was founded in 1996 and is headquartered in Chippenham, the United Kingdom.
Recent Trading Activity for Alliance Pharma plc (LON:APH)
Shares of Alliance Pharma plc closed the previous trading session at 81.60 −9.40 10.33% with 95.35 shares trading hands.